Veterinary Vaccines Market Analysis and Forecast to 2032: By Product (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Others), Animal Type (Companion Animal, Livestock Animal, and Aquaculture), and Region
The Veterinary Vaccines Market size was USD 9.4 Billion in 2022 and is anticipated to reach USD 15.7 Billion in 2032, growing at a rate of 5.3% from 2023 to 2032.
Veterinary vaccines are products used to stimulate an animal’s immune system to produce immunity against a specific disease. Vaccines are typically composed of one or more viruses, bacteria, or other microorganisms that have been modified or killed in order to reduce or eliminate their pathogenicity, and/or toxoids which are toxins that have been rendered harmless. Vaccines may also contain adjuvants, which are substances that are added to the vaccine to improve its efficacy.
Key Trends
The key trends in Veterinary Vaccines technology are:
1. The development of safer and more effective vaccines
2. The use of new technologies to improve vaccine efficacy
3. The development of new delivery systems for vaccines
4. The use of adjuvants to improve vaccine efficacy
Key Drivers
The key drivers of the veterinary vaccines market are the increasing demand for animal-derived products, the growing awareness of the importance of animal health, and the government support for the development of the veterinary vaccines industry. The other drivers include the technological advances in vaccine production and the increasing number of pet owners.
The demand for animal-derived products is increasing due to the growing population and the changing lifestyle. People are becoming more health-conscious and are demanding healthy and nutritious food. The animal-derived products provide the necessary nutrients and are also rich in protein. Government support is also playing a vital role in the development of the veterinary vaccines market. The government is providing financial assistance and other incentives to the companies involved in developing new vaccines.
Restraints & Challenges
The key restraints and challenges in the veterinary vaccines market are the lack of awareness about animal health and the lack of government support. In addition, the high cost of vaccines and the lack of access to veterinary care in some regions are other key challenges in this market.
Market Segments
The Veterinary Vaccines Market is segmented into product, animal type, and region. Based on product, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, and others. By animal type, the market is segmented into companion animal, livestock animal, and aquaculture. Region-wise, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World.
Key Players
The Veterinary Vaccines Market report includes players such as Merck & Co., Inc., Zoetis Inc., Ceva Santé Animale, Sanofi S.A., Romvac, Vaxxinova, Merial, Boehringer Ingelheim GmbH, HIPRA, and Anicon Labor GmbH.
Veterinary Vaccines Market Report Coverage
- The report offers a comprehensive quantitative as well as qualitative analysis of the current Veterinary Vaccines Market outlook and estimations from 2022 to 2032, which helps to recognize the prevalent opportunities.
- The report also covers qualitative as well as quantitative analysis of Veterinary Vaccines Market in terms of revenue ($Million).
- Major players in the market are profiled in this report and their key developmental strategies are studied in detail. This will provide an insight into the competitive landscape of the Veterinary Vaccines Market Industry.
- A thorough analysis of market trends and restraints is provided.
- By region as well as country market analysis is also presented in this report.
- Analytical depiction of the Veterinary Vaccines Market along with the current trends and future estimations to depict imminent investment pockets. The overall Veterinary Vaccines industry opportunity is examined by understanding profitable trends to gain a stronger foothold.
- Porter’s five forces analysis, SWOT analysis, Pricing Analysis, Case Studies, COVID-19 impact analysis, Russia-Ukraine war impact, and PESTLE analysis of the Veterinary Vaccines Market are also analyzed.
Table of Contents
Chapter 1. Market Introduction
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Methodologies
1.4. Market Estimation Techniques
Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market
Chapter 3. Veterinary Vaccines Market Outlook
3.1. Veterinary Vaccines Market segmentation
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.1.1. Driver 1
3.2.1.2. Driver 2
3.2.1.3. Driver 3
3.2.2. Market Restraints
3.2.2.1. Restraint 1
3.2.2.2. Restraint 2
3.2.3. Market Opportunities
3.2.3.1. Opportunity 1
3.2.3.2. Opportunity 2
3.3. Porter’s Five Forces Analysis
3.3.1. Threat of New Entrants
3.3.2. Threat of Substitutes
3.3.3. Bargaining Power of Buyers
3.3.4. Bargaining Power of Supplier
3.3.5. Competitive Rivalry
3.4. PESTLE Analysis
3.5. Value Chain Analysis
3.5.1. Raw Material Suppliers
3.5.2. Manufacturers
3.5.3. Wholesalers and/or Retailers
3.6. Impact of the Russia and Ukraine War on the Veterinary Vaccines Market
Chapter 4. Economic Impact of COVID-19
4.1. Overall Impact of COVID-19
4.2. Impact of COVID On the Veterinary Vaccines Market
4.3. Economic Impact Analysis
Chapter 5. Veterinary Vaccines Market By Animal Type
5.1. Market Overview
5.2. Companion animal
5.2.1. Market Size and Forecast, 2022-2032 ($Million)
5.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.3. Livestock animal
5.3.1. Market Size and Forecast, 2022-2032 ($Million)
5.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
5.4. Aquaculture
5.4.1. Market Size and Forecast, 2022-2032 ($Million)
5.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
Chapter 6. Veterinary Vaccines Market By Product
6.1. Market Overview
6.2. Attenuated Vaccines
6.2.1. Market Size and Forecast, 2022-2032 ($Million)
6.2.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.3. Inactivated Vaccines
6.3.1. Market Size and Forecast, 2022-2032 ($Million)
6.3.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.4. Subunit Vaccines
6.4.1. Market Size and Forecast, 2022-2032 ($Million)
6.4.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.5. Toxoid Vaccines
6.5.1. Market Size and Forecast, 2022-2032 ($Million)
6.5.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.6. Conjugate Vaccines
6.6.1. Market Size and Forecast, 2022-2032 ($Million)
6.6.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
6.7. Others
6.7.1. Market Size and Forecast, 2022-2032 ($Million)
6.7.2. Market Size and Forecast, by Region, 2022-2032 ($Million)
Chapter 7. Veterinary Vaccines Market, by region
7.1. Overview
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. North America Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.2.3. North America Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.2.4. The U.S.
7.2.4.1. The U.S. Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.2.4.2. The U.S. Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.2.5. Canada
7.2.5.1. Canada Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.2.5.2. Canada Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.2.6. Mexico
7.2.6.1. Mexico Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.2.6.2. Mexico Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Europe Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.3. Europe Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.4. Germany
7.3.4.1. Germany Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.4.2. Germany Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.5. France
7.3.5.1. France Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.5.2. France Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.6. U.K.
7.3.6.1. U.K. Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.6.2. U.K. Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.7. Spain
7.3.7.1. Spain Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.7.2. Spain Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.8. Italy
7.3.8.1. Italy Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.8.2. Italy Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.3.9. Rest of Europe
7.3.9.1. Rest of Europe Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.3.9.2. Rest of Europe Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Asia-Pacific Veterinary Vaccines Market Size and Forecast by Country, 2022-2032, ($Million)
7.4.3. Asia-Pacific Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4.4. China
7.4.4.1. China Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.4.4.2. China Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4.5. India
7.4.5.1. India Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.4.5.2. India Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4.6. Japan
7.4.6.1. Japan Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.4.6.2. Japan Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4.7. South Korea
7.4.7.1. South Korea Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.4.7.2. South Korea Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.4.8. Rest of APAC
7.4.8.1. Rest of APAC Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.4.8.2. Rest of APAC Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.5. Rest of the World
7.5.1. Key Market Trends and Opportunities
7.5.2. Rest of the World Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.5.3. Rest of the World Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.5.4. Latin America
7.5.4.1. Latin America Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.5.4.2. Latin America Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.5.5. Middle East
7.5.5.1. Middle East Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.5.5.2. Middle East Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
7.5.6. Africa
7.5.6.1. Africa Veterinary Vaccines Market Size and Forecast By Animal Type, 2022-2032, ($Million)
7.5.6.2. Africa Veterinary Vaccines Market Size and Forecast By Product, 2022-2032, ($Million)
Chapter 8. Competitive Landscape
8.1. Market Overview
8.2. Market Share Analysis/Key Player Positioning
8.3. Developmental Strategy Benchmarking
8.3.1. New Product Development
8.3.2. Product Launches
8.3.3. Business Expansions
8.3.4. Partnerships, Joint Ventures, and Collaborations
8.3.5. Mergers and Acquisitions
Chapter 9. Company Profiles
9.1. Merck & Co., Inc
9.1.1. Company Snapshot
9.1.2. Financial Performance
9.1.3. Product Offerings
9.1.4. Key Strategic Initiatives
9.1.5. SWOT Analysis
9.2. Zoetis Inc
9.2.1. Company Snapshot
9.2.2. Financial Performance
9.2.3. Product offerings
9.2.4. Key Strategic Initiatives
9.2.5. SWOT Analysis
9.3. Ceva Santé Animale
9.3.1. Company Snapshot
9.3.2. Financial Performance
9.3.3. Product offerings
9.3.4. Key Strategic Initiatives
9.3.5. SWOT Analysis
9.4. Sanofi S.A.
9.4.1. Company Snapshot
9.4.2. Financial Performance
9.4.3. Product offerings
9.4.4. Key Strategic Initiatives
9.4.5. SWOT Analysis
9.5. Romvac
9.5.1. Company Snapshot
9.5.2. Financial Performance
9.5.3. Product offerings
9.5.4. Key Strategic Initiatives
9.5.5. SWOT Analysis
9.6. Vaxxinova
9.6.1. Company Snapshot
9.6.2. Financial Performance
9.6.3. Product offerings
9.6.4. Key Strategic Initiatives
9.6.5. SWOT Analysis
9.7. Anicon Labor GmbH
9.7.1. Company Snapshot
9.7.2. Financial Performance
9.7.3. Product offerings
9.7.4. Key Strategic Initiatives
9.7.5. SWOT Analysis
9.8. Merial
9.8.1. Company Snapshot
9.8.2. Financial Performance
9.8.3. Product offerings
9.8.4. Key Strategic Initiatives
9.8.5. SWOT Analysis
9.9. Boehringer Ingelheim GmbH
9.9.1. Company Snapshot
9.9.2. Financial Performance
9.9.3. Product offerings
9.9.4. Key Strategic Initiatives
9.9.5. SWOT Analysis
9.10. HIPRA
9.10.1. Company Snapshot
9.10.2. Financial Performance
9.10.3. Product offerings
9.10.4. Key Strategic Initiatives
9.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report
Key Players
- Merck & Co., Inc.
- Zoetis Inc.
- Ceva Santé Animale
- Sanofi S.A.
- Romvac
- Vaxxinova
- Merial
- Boehringer Ingelheim GmbH
- Anicon Labor GmbH
- HIPRA
Market Segments
By Product
- Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- Conjugate Vaccines
- Others
By Animal Type
- Companion Animal
- Livestock Animal
- Aquaculture
By Region
- North America
- The U.S.
- Canada
- Mexico
- Europe
- The U.K.
- Germany
- France
- Spain
- Italy
- Netherlands
- Sweden
- Switzerland
- Denmark
- Finland
- Russia
- Rest of Europe
- The Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Singapore
- Indonesia
- Taiwan
- Malaysia
- Rest of Asia-Pacific
- Rest of the World
- Latin America
- The Middle East
- Africa